It also removes a major source of variability reconstituting, measuring, and administering four separate compounds which is why the KLOW 80mg peptide blend for multi-pathway research has become a standard tool in comparative repair studies

Risks/ disadvantages of GLP-1 agonists: Nausea and vomiting (far less likely when starting on a very low dose and titrating up slowly) Diarrhoea Dizziness and tiredness Mild tachycardia (increased heart rate) Headaches Temporary itchiness /redness around injection sites Dry mouth/reduced salivary secretions Low blood sugar Rare but more serious side effects: Pancreatitis More serious gut side effects because of stagnated gut movement Medullary thyroid cancer Sudden kidney injury (usually because of reduced volume intake or vomiting) Worsening of diabetic retinopathy (diabetes related eye disease) Allergic reactions Gallbladder or biliary disease Depression and suicidal ideation Aspiration (food or liquid getting into lungs) during anaesthesia as the stomach empties more slowly- ideally the medication should be stopped for 2-4 weeks prior to elective surgery

"Ending this project was bittersweet, because it was my last collaboration with him." "He was always asking, 'How do we help people the fastest?' Using a drug that's already shown to be safe to help people reduce drinking could be a way to get people help fast," DiFeliceantonio said
Gut inflammation and other dysbiosis can certainly lead to nutritional insufficiency as the gut becomes less efficient at absorbing nutrients
The argument for earlier intervention is strongest when the lifetime exposure trajectory is clearly unfavourable, not when the short-term score is simply low